Due to the lack of proper single-cell sequencing data from melanoma patients, we could only partly confirm our findings using clinical bulk data, while the prognostic role of different populations of CD8+ T cells could not be defined based on the bulk data from melanoma patients treated with anti-PD1/PD-L1. This evidence concerns the gene CD8A and melanoma.